{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:27:54Z","timestamp":1794565674834,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/md.0000000000007766","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:46:14Z","timestamp":1502844374000},"page":"e7766","source":"Crossref","is-referenced-by-count":24,"title":["Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA"],"prefix":"10.1097","volume":"96","author":[{"given":"Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinfen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hainv","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-22-20210309","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhep.2004.03.025","article-title":"B virus genotypes, core gene variability and ethnicity in the Pacific region","volume":"41","author":"Jazayeri","year":"2004","journal-title":"J Hepatol"},{"key":"R3-22-20210309","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/hep.1840070424","article-title":"Chronic type B hepatitis and the \u201chealthy\u201d HBsAg carrier state","volume":"7","author":"Hoofnagle","year":"1987","journal-title":"Hepatology"},{"key":"R4-22-20210309","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-118-3-199302010-00006","article-title":"The natural history of asymptomatic hepatitis B surface antigen carriers","volume":"11","author":"de Franchis","year":"1993","journal-title":"Ann Intern Med"},{"key":"R5-22-20210309","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China: declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"key":"R6-22-20210309","first-page":"2925","article-title":"Prevention of hepatitis B in China: achievements and challenges","volume":"122","author":"Lu","year":"2009","journal-title":"Chin Med J"},{"key":"R7-22-20210309","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"R8-22-20210309","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2015.01.020","article-title":"Causes of death in people with chronic HBV infection: a population-based cohort study","volume":"62","author":"Montuclard","year":"2015","journal-title":"J Hepatol"},{"key":"R9-22-20210309","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3349\/ymj.1996.37.5.295","article-title":"Peritoneoscopic liver biopsy findings in asymptomatic chronic HBsAg carriers with normal liver function tests and no hepatomegaly","volume":"37","author":"Chon","year":"1996","journal-title":"Yonsei Med J"},{"key":"R10-22-20210309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-0934(98)00081-0","article-title":"Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay","volume":"74","author":"Gerken","year":"1998","journal-title":"J Virol Methods"},{"key":"R11-22-20210309","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1053\/jhep.2003.50208","article-title":"Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature","volume":"37","author":"Mommeja-Marin","year":"2003","journal-title":"Hepatology"},{"key":"R12-22-20210309","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1111\/j.1365-2893.2011.01437.x","article-title":"Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B","volume":"18","author":"Sanai","year":"2011","journal-title":"J Viral Hepat"},{"key":"R13-22-20210309","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0168-8278(99)80247-5","article-title":"The role of HBV DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection","volume":"30","author":"Nagata","year":"1999","journal-title":"J Hepatol"},{"key":"R14-22-20210309","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4103\/0366-6999.160488","article-title":"Baseline hepatitis B virus DNA level is a promising factor for predicting the 3rd month virological response to entecavir therapy: a study of strict defined hepatitis B virus induced cirrhosis","volume":"128","author":"Xu","year":"2015","journal-title":"Chin Med J"},{"key":"R15-22-20210309","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0168-8278(96)80263-7","article-title":"The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection","volume":"24","author":"Jardi","year":"1996","journal-title":"J Hepatol"},{"key":"R16-22-20210309","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3329\/bmrcb.v34i2.1173","article-title":"HBeAg\/anti-HBe, alanine aminotransferase and HBV DNA levels in HBsAg positive chronic carriers","volume":"34","author":"Rabbi","year":"2008","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"R17-22-20210309","first-page":"110","article-title":"Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg\/anti-HBe, and liver function tests","volume":"33","author":"Hasan","year":"2002","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R18-22-20210309","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/1319-3767.121035","article-title":"Correlation between hepatitis B surface antigen titers and HBV DNA levels","volume":"19","author":"Alghamdi","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"R19-22-20210309","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"R20-22-20210309","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"R21-22-20210309","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa020681","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B","volume":"348","author":"Marcellin","year":"2003","journal-title":"N Engl J Med"},{"key":"R22-22-20210309","doi-asserted-by":"crossref","first-page":"439","DOI":"10.5694\/j.1326-5377.1986.tb113868.x","article-title":"Relationship between HBeAg and HBV DNA in subjects with acute and persistent hepatitis B infection","volume":"145","author":"Gowans","year":"1986","journal-title":"Med J Aust"},{"key":"R23-22-20210309","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/jmv.1890390408","article-title":"Correlation of HBeAg\/anti-HBe, ALT levels, and HBV DNA PCR results in HBsAg-positive subjects","volume":"39","author":"Ljunggren","year":"1993","journal-title":"J Med Virol"},{"key":"R24-22-20210309","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJM199605303342202","article-title":"Long-term follow-up of HBeAg-positive subjects treated with interferon alfa for chronic hepatitis B","volume":"334","author":"Niederau","year":"1996","journal-title":"N Engl J Med"},{"key":"R25-22-20210309","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1053\/jhep.2003.50453","article-title":"Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection","volume":"38","author":"Milich","year":"2003","journal-title":"Hepatology"},{"key":"R26-22-20210309","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3748\/wjg.v9.i1.108","article-title":"HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection","volume":"9","author":"Du","year":"2003","journal-title":"World J Gastroenterol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000007766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:57:00Z","timestamp":1620961020000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201708180-00022"}},"subtitle":["A community-based study"],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":25,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000007766","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}